RPID · Rapid Micro Biosystems, Inc.
Market Cap
$78.50M
Shares
50.16M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-07 | — | |
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-05-28 | 2026-05-21 | |
| 8-K | 2026-05-19 | 2026-05-18 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-13 | — | |
| DEF 14A | 2026-04-08 | 2026-05-21 | |
| 8-K | 2026-03-27 | 2026-03-23 | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| Investor Event Transcript | 2026-03-03 | 2026-03-31 | |
| 8-K | 2026-01-13 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-07 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | 2025-08-08 | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-05-23 | 2025-05-22 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | — | |
| DEF 14A | 2025-04-08 | 2025-05-22 | |
| 8-K | 2025-03-04 | — | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-28 | — | |
| 8-K | 2025-02-27 | 2025-02-21 | |
| 8-K | 2025-01-16 | — | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-01 | 2024-10-29 | |
| 10-Q | 2024-08-02 | 2024-06-30 | |
| 8-K | 2024-08-02 | — | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-05-03 | — | |
| 10-Q | 2024-05-03 | 2024-03-31 | |
| DEF 14A | 2024-04-09 | 2024-05-23 | |
| 8-K | 2024-03-01 | — | |
| 10-K | 2024-03-01 | 2023-12-31 | |
| 8-K | 2024-02-02 | — | |
| 8-K | 2024-01-10 | — | |
| 8-K | 2023-11-03 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-09-26 | — | |
| 8-K | 2023-09-19 | 2023-09-13 | |
| 10-Q | 2023-08-04 | 2023-06-30 | |
| 8-K | 2023-08-04 | — | |
| 8-K | 2023-07-18 | 2023-07-14 | |
| 10-K/A | 2023-05-15 | 2022-12-31 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-08 | 2023-05-04 |
Showing 1–50 of 75 filings
Key facts
CIK
1380106
CUSIP
75340L104
13F (30d)
34 filings
33 filers
Visit website
Investor relations